Parallax Volatility Advisers’s Abiomed Inc ABMD Stock Holding History

Parallax Volatility Advisers’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-61	Closed	-$20.7K	–	3584
2021 Q2	$19K	Sell	61 -206	-77%	-$63.2K	﹤0.01%	2734
2021 Q1	$85K	Sell	267 -3,600	-93%	-$1.15M	﹤0.01%	2870
2020 Q4	$1.25M	Buy	3,867 +266	+7%	+$73.6K	﹤0.01%	2084
2020 Q3	$998K	Buy	3,601 +2,303	+177%	+$663K	﹤0.01%	1986
2020 Q2	$314K	Sell	1,298 -12,446	-91%	-$2.5M	﹤0.01%	2127
2020 Q1	$2M	Buy	+13,744	New	+$2.28M	﹤0.01%	1235
2019 Q3	–	Sell	-69	Closed	-$18K	–	3740
2019 Q2	$18K	Sell	69 -17,753	-100%	-$4.71M	﹤0.01%	2104
2019 Q1	$5.09M	Buy	17,822 +16,763	+1,583%	+$5.57M	0.01%	689
2018 Q4	$344K	Buy	+1,059	New	+$368K	﹤0.01%	1604
2018 Q3	–	Sell	-3,619	Closed	-$1.43M	–	3843
2018 Q2	$1.48M	Buy	+3,619	New	+$1.31M	﹤0.01%	990

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Parallax Volatility Advisers's ABMD Position: Q3 2021 in Review

Parallax Volatility Advisers sold out of Abiomed Inc (ABMD) in Q3 2021, closing a stake of 61 shares — an estimated $20.7K sold.

Parallax Volatility Advisers first reported a position in ABMD in Q2 2018 and held it in 10 quarters. The position peaked at $5.09M in Q1 2019. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2021.

Parallax Volatility Advisers reported no remaining Abiomed Inc position as of Q3 2021 after selling out during the quarter.
Parallax Volatility Advisers sold 61 Abiomed Inc shares in Q3 2021, an estimated $20.7K.
Parallax Volatility Advisers first reported a position in Abiomed Inc in Q2 2018 and held it in 10 quarters.
Parallax Volatility Advisers's Abiomed Inc position peaked at $5.09M in Q1 2019.
498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2021.

Based on Parallax Volatility Advisers's 13F filing for Q3 2021, filed 15 Nov 2021.